AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Fangdd Network Group Ltd.

$0.5 -$1.07 (-68.31%)
NASDAQ · 14 Sep 2026 16:06 UTC
Previous Close
$0.51
Day Range
$0.49$0.51
Year Range
$0.49$4.33
Market Cap
3.96M
AVG Volume
929.49K
Trailing/Forward PE
-0.6/-
PEG ratio
0
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
NASDAQUS
Revenue (CNY)
050M100M150M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO Revenue (CNY) by quarter
PeriodRevenue (CNY)
26 Q257.87M
26 Q157.87M
25 Q475.71M
25 Q375.71M
25 Q2101.7M
25 Q1101.7M
24 Q499.57M
24 Q399.57M
24 Q269.98M
24 Q169.98M
Net Income (CNY)
-30M-20M-10M010M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO Net Income (CNY) by quarter
PeriodNet Income (CNY)
26 Q2-17.02M
26 Q1-17.02M
25 Q4-23.3M
25 Q3-23.3M
25 Q2-19.06M
25 Q1-19.06M
24 Q46.72M
24 Q36.72M
24 Q28.69M
24 Q18.69M
Operating Income (CNY)
-40M-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO Operating Income (CNY) by quarter
PeriodOperating Income (CNY)
26 Q2-12.96M
26 Q1-12.96M
25 Q4-30.77M
25 Q3-30.77M
25 Q2-35.88M
25 Q1-35.88M
24 Q4-28.52M
24 Q3-28.52M
24 Q2-34.31M
24 Q1-34.31M
EBITDA (CNY)
-40M-30M-20M-10M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO EBITDA (CNY) by quarter
PeriodEBITDA (CNY)
26 Q2-8.29M
26 Q1-8.29M
25 Q4-21.92M
25 Q3-21.92M
25 Q2-35.76M
25 Q1-35.76M
24 Q4-28.41M
24 Q3-28.41M
24 Q2-34.19M
24 Q1-34.19M
Cash Flows (CNY)
-100M-75M-50M-25M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO Cash Flows (CNY) by quarter
PeriodCash Flows (CNY)
26 Q20
26 Q10
25 Q4-83.6M
25 Q3-19.27M
25 Q2-22.54M
25 Q1-22.54M
24 Q4-42.32M
24 Q3-42.32M
24 Q2-3.48M
24 Q1-3.48M
EPS (CNY)
-7.5-5-2.502.524 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO EPS (CNY) by quarter
PeriodEPS (CNY)
26 Q2-0.44
26 Q1-0.44
25 Q4-2.32
25 Q3-2.32
25 Q2-6.33
25 Q1-6.33
24 Q40.48
24 Q30.48
24 Q22.35
24 Q12.35
Expenses (CNY)
-20M020M40M60M80MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO Expenses (CNY) by quarter
PeriodExpenses (CNY)
26 Q220.61M
26 Q120.61M
25 Q476.75M
25 Q353.12M
25 Q257.03M
25 Q157.03M
24 Q465.73M
24 Q365.73M
24 Q243.59M
24 Q143.59M
Cash & Debt (CNY)
050M100M150M200MCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO Cash & Debt (CNY) by quarter
PeriodCash & Debt (CNY)
26 Q2103.34M
26 Q1103.34M
25 Q4144.2M
25 Q3144.2M
25 Q2178.38M
25 Q1178.38M
24 Q4188.98M
24 Q3188.98M
24 Q2137.27M
24 Q1137.27M
Debt ratios
00.511.5224 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO Debt ratios by quarter
PeriodDebt ratios
26 Q21.71
26 Q11.17
25 Q41.24
25 Q31.18
25 Q21.31
25 Q11.33
24 Q41.5
24 Q30.96
24 Q20.51
24 Q10.51
Margins
0%10%20%30%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO Margins by quarter
PeriodMargins
26 Q213.22%
26 Q113.22%
25 Q429.81%
25 Q329.81%
25 Q29.07%
25 Q19.07%
24 Q422.24%
24 Q322.24%
24 Q212.47%
24 Q112.47%
Return on Capital
-5%-2.5%0%2.5%5%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO Return on Capital by quarter
PeriodReturn on Capital
26 Q2-3.25%
26 Q1-3.25%
25 Q4-4.02%
25 Q3-4.02%
25 Q2-5%
25 Q1-5%
24 Q41.75%
24 Q31.75%
24 Q24.11%
24 Q14.11%
Shares Outstanding
010M20M30M40M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO Shares Outstanding by quarter
PeriodShares Outstanding
26 Q238.55M
26 Q138.55M
25 Q410.06M
25 Q310.06M
25 Q23.01M
25 Q13.01M
24 Q414.15M
24 Q314.15M
24 Q23.7M
24 Q13.7M
Book Value Per Share (CNY)
05010015024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO Book Value Per Share (CNY) by quarter
PeriodBook Value Per Share (CNY)
26 Q213.58
26 Q113.58
25 Q457.54
25 Q357.54
25 Q2126.64
25 Q1126.64
24 Q427.09
24 Q327.09
24 Q257.09
24 Q157.09
Total Assets (CNY)
0200M400M600M800M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
DUO Total Assets (CNY) by quarter
PeriodTotal Assets (CNY)
26 Q2701.14M
26 Q1701.14M
25 Q4788.26M
25 Q3788.26M
25 Q2679M
25 Q1679M
24 Q4731.19M
24 Q3731.19M
24 Q2673.95M
24 Q1673.95M
Employee Count
05001K1.5K2K2019202020212022202320242025
DUO Employee Count by quarter
PeriodEmployee Count
2025144
2024134
2023130
2022212
2021604
20201.73K
20191.68K
PE Ratio
0200400600800med 17.55Jan 20Feb 20May 25Jun 25Jul 25Aug 25Sep 25
DUO PE Ratio by quarter
PeriodPE Ratio
Sep 2523
Sep 2525.72
Sep 2523.52
Sep 2523.97
Aug 2516.65
Aug 2510.15
Aug 2510.59
Aug 2511.79
Aug 2512.47
Jul 2515.2
Jul 2515.08
Jul 2515.62
Jul 2516.25
Jun 2515.27
Jun 2518.11
Jun 2516.98
Jun 2522.47
May 2522.79
May 2512.09
May 2512.7
May 2512.29
May 2512.21
Apr 2513.38
Feb 20466.88
Feb 20528.92
Feb 20525.94
Feb 20497.48
Jan 20521.42
Jan 20577.88
Jan 20582.88
Jan 20592.56
Jan 20618.03
Free Cash Flow Yield
-400%-300%-200%-100%0%med -95.83%Jan 25May 25Aug 25Nov 25Feb 26Jun 26Sep 26
DUO Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-77.86%
Sep 26-69.04%
Aug 26-41.32%
Aug 26-70.21%
Aug 26-75.88%
Aug 26-76.53%
Jul 26-84.13%
Jul 26-84.58%
Jul 26-87.12%
Jul 26-76.06%
Jul 26-64.77%
Jun 26-71.83%
Jun 26-55.89%
Jun 26-54.51%
Jun 26-48.09%
May 26-195.8%
May 26-200.4%
May 26-162.37%
May 26-148.11%
May 26-100.19%
Apr 26-109.23%
Apr 26-110.31%
Apr 26-129.4%
Apr 26-141.27%
Mar 26-140.74%
Mar 26-148.06%
Mar 26-136.06%
Mar 26-141.04%
Feb 26-132.14%
Feb 26-137.04%
Feb 26-128.98%
Feb 26-127.32%
Jan 26-108.18%
Jan 26-103.58%
Jan 26-95.1%
Jan 26-94.97%
Jan 26-96.57%
Dec 25-91.71%
Dec 25-89.63%
Dec 25-77.07%
Dec 25-72.1%
Nov 25-336.55%
Nov 25-360.98%
Nov 25-335.41%
Nov 25-308.75%
Oct 25-307.4%
Oct 25-270.19%
Oct 25-229.95%
Oct 25-179.8%
Oct 25-192.8%
Sep 25-156.2%
Sep 25-139.66%
Sep 25-152.69%
Sep 25-149.85%
Aug 25-215.75%
Aug 25-353.89%
Aug 25-339.04%
Aug 25-304.64%
Aug 25-288.04%
Jul 25-236.38%
Jul 25-238.25%
Jul 25-230.01%
Jul 25-221.08%
Jun 25-235.16%
Jun 25-198.29%
Jun 25-211.57%
Jun 25-159.83%
May 25-157.63%
May 25-24.57%
May 25-23.39%
May 25-24.18%
May 25-24.33%
Apr 25-22.21%
Apr 25-16.2%
Apr 25-16.8%
Apr 25-14.02%
Mar 25-12.49%
Mar 25-11.65%
Mar 25-9.08%
Mar 25-7.81%
Feb 25-7.51%
Feb 25-6.53%
Feb 25-5.71%
Feb 25-6.22%
Jan 25-6.43%
Jan 25-6.5%
Jan 25-6.17%
Jan 25-6.99%
Jan 25-5.68%
Dec 24-5.79%
Dec 24-5.8%
Dec 24-5.21%
Dec 24-6.56%
Nov 24-6.57%
Price to Sales
01234med 0.31Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
DUO Price to Sales by quarter
PeriodPrice to Sales
Sep 260.49
Sep 260.56
Aug 260.93
Aug 260.57
Aug 260.53
Aug 260.53
Jul 260.48
Jul 260.48
Jul 260.46
Jul 260.53
Jul 260.62
Jun 260.56
Jun 260.72
Jun 260.74
Jun 260.84
May 260.21
May 260.21
May 260.26
May 260.28
May 260.28
Apr 260.26
Apr 260.26
Apr 260.22
Apr 260.2
Mar 260.2
Mar 260.19
Mar 260.21
Mar 260.2
Feb 260.21
Feb 260.21
Feb 260.22
Feb 260.22
Jan 260.26
Jan 260.27
Jan 260.3
Jan 260.3
Jan 260.29
Dec 250.31
Dec 250.31
Dec 250.37
Dec 250.39
Nov 250.1
Nov 250.09
Nov 250.1
Nov 250.1
Oct 250.1
Oct 250.12
Oct 250.14
Oct 250.18
Oct 250.17
Sep 250.19
Sep 250.21
Sep 250.2
Sep 250.2
Aug 250.14
Aug 250.08
Aug 250.09
Aug 250.1
Aug 250.1
Jul 250.13
Jul 250.13
Jul 250.13
Jul 250.13
Jun 250.13
Jun 250.15
Jun 250.14
Jun 250.19
May 250.19
May 251.1
May 251.16
May 251.12
May 251.11
Apr 251.22
Apr 251.26
Apr 251.22
Apr 251.46
Mar 251.64
Mar 251.75
Mar 252.25
Mar 252.62
Feb 252.72
Feb 253.13
Feb 253.58
Feb 253.29
Jan 253.18
Jan 253.14
Jan 253.31
Jan 252.92
Jan 253.6
Dec 243.53
Dec 243.52
Dec 243.92
Dec 243.12
Nov 243.11
Nov 240.83
Nov 241.03
Nov 241.69
Nov 241.71
Oct 241.68
Oct 241.8
EV/EBITDA
550600650700750med 640.29Jan 20Jan 20Jan 20Feb 20Feb 20
DUO EV/EBITDA by quarter
PeriodEV/EBITDA
Feb 20565.1
Feb 20640.29
Feb 20636.67
Feb 20602.18
Jan 20631.2
Jan 20699.64
Jan 20705.69
Jan 20717.42
Jan 20748.3
Price to Book
01234med 0.21Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
DUO Price to Book by quarter
PeriodPrice to Book
Sep 260.25
Sep 260.28
Aug 260.48
Aug 260.34
Aug 260.32
Aug 260.31
Jul 260.28
Jul 260.28
Jul 260.27
Jul 260.31
Jul 260.37
Jun 260.33
Jun 260.43
Jun 260.44
Jun 260.5
May 260.13
May 260.13
May 260.16
May 260.17
May 260.18
Apr 260.17
Apr 260.17
Apr 260.14
Apr 260.13
Mar 260.13
Mar 260.12
Mar 260.14
Mar 260.13
Feb 260.14
Feb 260.13
Feb 260.14
Feb 260.14
Jan 260.17
Jan 260.18
Jan 260.19
Jan 260.19
Jan 260.19
Dec 250.2
Dec 250.21
Dec 250.24
Dec 250.26
Nov 250.1
Nov 250.09
Nov 250.1
Nov 250.11
Oct 250.11
Oct 250.13
Oct 250.15
Oct 250.19
Oct 250.18
Sep 250.19
Sep 250.21
Sep 250.19
Sep 250.19
Aug 250.13
Aug 250.08
Aug 250.09
Aug 250.1
Aug 250.1
Jul 250.12
Jul 250.12
Jul 250.13
Jul 250.13
Jun 250.12
Jun 250.15
Jun 250.14
Jun 250.18
May 250.18
May 250.97
May 251.02
May 250.99
May 250.98
Apr 251.08
Apr 251.01
Apr 250.97
Apr 251.16
Mar 251.3
Mar 251.4
Mar 251.79
Mar 252.08
Feb 252.17
Feb 252.49
Feb 252.85
Feb 252.62
Jan 252.53
Jan 252.5
Jan 252.64
Jan 252.33
Jan 252.86
Dec 242.81
Dec 242.81
Dec 243.12
Dec 242.48
Nov 242.48
Nov 241.06
Nov 241.32
Nov 242.17
Nov 242.2
Oct 242.15
Oct 242.31
Fangdd Network Group Ltd.
DUO
Stockpicker

Video analysis: DUO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: DUO

FangDD Reports First Half 2026 Unaudited Financial Results

globenewswire.com · 28 Aug 2026

FangDD Reports First Half 2026 Unaudited Financial Results

SHENZHEN, China, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (NASDAQ: DUO) (“FangDD” or “the Company”), a customer-oriented property technology company in China, today announced its unaudited financial results for the six months ended June 30, 2026.

FangDD Received Nasdaq Notification Regarding Minimum Bid Price Requirement

globenewswire.com · 24 Jul 2026

FangDD Received Nasdaq Notification Regarding Minimum Bid Price Requirement

SHENZHEN, China, July 24, 2026 (GLOBE NEWSWIRE) -- Fangdd Network Group Ltd. (Nasdaq: DUO) (“FangDD” or the “Company”) today announced that it has received a written notification from The Nasdaq Stock Market LLC (“Nasdaq”) dated July 22, 2026, indicating that the Company is currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2) (the “Rule”) as the bid price of the Company's Class A ordinary shares had closed below US$1 per share for the last 30 consecutive business days from June 8 through July 21, 2026.

CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study

businesswire.com · 23 Jun 2026

CroíValve Announces Expansion of Series B Financing with $27 Million Additional Capital to Fund DUO Adapt in an Enlarged TANDEM II Study

DUBLIN--(BUSINESS WIRE)--CroíValve, a pioneering medical device company focused on the development of a novel transcatheter device for the treatment of tricuspid regurgitation, announced today the closing of $20 million Series B expansion financing, along with $7 million European Innovation Council (EIC) and DTIF grant financing. Bringing the total for Series B to $36 million, and $43M including grant financing. The financing includes new investors BGF and EIC, along with participation from cur.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.